Overview
Welcome to Dwaey, specifically on NOVOSEVEN 4.8mg (240KIU) Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant).
NOVOSEVEN 4.8mg (240KIU) is available in the market in concentration 4.8mg (240 KIU)/Vial and in the form of Injection/Powder for.
NOVO NORDISK A/S is the producer of NOVOSEVEN 4.8mg (240KIU) and it is imported from DENMARK, The most popular alternatives of NOVOSEVEN 4.8mg (240KIU) are listed downward .
Pregnancy category:
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)
Coagulation Factor VIIa (Eptacog alfa -activated) (Recombinant)